<code id='8F94F58C01'></code><style id='8F94F58C01'></style>
    • <acronym id='8F94F58C01'></acronym>
      <center id='8F94F58C01'><center id='8F94F58C01'><tfoot id='8F94F58C01'></tfoot></center><abbr id='8F94F58C01'><dir id='8F94F58C01'><tfoot id='8F94F58C01'></tfoot><noframes id='8F94F58C01'>

    • <optgroup id='8F94F58C01'><strike id='8F94F58C01'><sup id='8F94F58C01'></sup></strike><code id='8F94F58C01'></code></optgroup>
        1. <b id='8F94F58C01'><label id='8F94F58C01'><select id='8F94F58C01'><dt id='8F94F58C01'><span id='8F94F58C01'></span></dt></select></label></b><u id='8F94F58C01'></u>
          <i id='8F94F58C01'><strike id='8F94F58C01'><tt id='8F94F58C01'><pre id='8F94F58C01'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:451

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          With trial win, GSK could get blood cancer drug back on market
          With trial win, GSK could get blood cancer drug back on market

          JUSTINTALLIS/AFPviaGettyImagesLONDON—TheresurrectionofaGSKbloodcancerdrug—whichthecompanywithdrewfro

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Pharma companies must ensure equitable access to obesity drugs

          TheobesitydrugWegovyisseenatapharmacyinChicago.ScottOlson/GettyImagesWeightlosstreatmentshavethepote